Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Preparing for Health Care Reform: Why Big Pharma Thinks it Can Avoid Another "Hillarycare"

This article was originally published in RPM Report

Executive Summary

Should a Democrat take the White House next January, top pharmaceutical executives expect a serious push for health care reform. The prospect of a health care reform debate triggers the specter of a single-payor, government-run system with price controls. But Democrats are singing a surprisingly soothing tune.

You may also be interested in...

Lilly, Anthem Singing Same Tune On Value-Based Pricing, Communication Policy

“Project Indy” offers a joint manufacturer/payor perspective on how to enable value based pricing. It also sounds like a potential proposal to CMS to volunteer for a pilot project.

The Differences Between the Obama and Bush White House: A Look Ahead

Former HHS general counsel Dan Meron, now a partner at Latham & Watkins, was asked to make predictions on how the Obama Administration would differ from the Bush Administration in a recent speech to the annual meeting of the Food, Drug and Cosmetic Law Section of the New York Bar Association. His remarks were edited for continuity.

Former CMS Chief Scully’s Perspective On The Changes In Washington

In a speech before the Food and Drug Law Institute's conference on collaboration between CMS and FDA, Tom Scully, with his usual candor and humor, gave his views on what the outcome of the national elections could mean to the health care industry and on some of the proposals being floated in Washington. Below are some excerpts from his presentation on Nov. 18 in Washington, D.C. Scully served as CMS administrator from 2001 to 2003. He currently divides his time between the law firm Alston & Bird, where he is senior counsel, and the private equity firm Welsh, Carson, Anderson & Stowe, where he is a general partner.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts